The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2023 | Rivard Paul | Chief Legal Officer | Buy(P) | 150K | $1.11 | $167K |
| Aug 17, 2023 | Rivard Paul | Chief Legal Officer | Buy(P) | 25K | $1.12 | $28K |
| Jun 7, 2023 | Kaplin Adam | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Jun 7, 2023 | White Billy Joe | Director | Grant(A) | 150K | — | $0 |
| Jun 7, 2023 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 300K | — | $0 |
| Jun 7, 2023 | Schreiber Christopher C | Director | Grant(A) | 150K | — | $0 |
| Jun 7, 2023 | Eagle Craig | Director | Grant(A) | 475K | — | $0 |
| Jun 7, 2023 | Silverman Joshua | Director | Grant(A) | 200K | — | $0 |
| Jun 7, 2023 | Uzonwanne Jude | Director | Grant(A) | 150K | — | $0 |
| Jun 7, 2023 | Rivard Paul | Chief Legal Officer | Grant(A) | 150K | — | $0 |
| Apr 4, 2023 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 750K | — | $0 |
| Dec 8, 2022 | Rivard Paul | EVP of Operations, GC | Buy(P) | 10K | $1.53 | $15K |
| Nov 26, 2021 | Silverman Joshua | Director | Buy(P) | 5K | $7.55 | $38K |
| Nov 24, 2021 | Silverman Joshua | Director | Buy(P) | 3K | $7.09 | $23K |
| Nov 24, 2021 | Silverman Joshua | Director | Buy(P) | 7K | $6.30 | $42K |
| Nov 23, 2021 | Rivard Paul | EVP of Operations, GC | Buy(P) | 15K | $6.03 | $90K |
| Oct 14, 2021 | Rivard Paul | EVP of Operations, GC | Grant(A) | 200K | — | $0 |
| Oct 14, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 600K | — | $0 |
| Oct 14, 2021 | Silverman Joshua | Director | Grant(A) | 600K | — | $0 |
| Oct 14, 2021 | Eagle Craig | Director | Grant(A) | 150K | — | $0 |
| Oct 14, 2021 | Uzonwanne Jude | Director | Grant(A) | 150K | — | $0 |
| Oct 14, 2021 | White Billy Joe | Director | Grant(A) | 150K | — | $0 |
| Oct 14, 2021 | Schreiber Christopher C | Director | Grant(A) | 150K | — | $0 |
| Oct 14, 2021 | Kaplin Adam | Chief Scientific Officer | Grant(A) | 600K | — | $0 |
| Apr 16, 2021 | Eagle Craig | Director | Grant(A) | 482K | — | — |
| Apr 16, 2021 | Kaplin Adam | Chief Scientific Officer | Grant(A) | 154K | — | — |
| Apr 16, 2021 | Schreiber Christopher C | Director | Option exercise(M) | 132K | — | $0 |
| Apr 16, 2021 | Schreiber Christopher C | Director | Tax withholding(F) | 46K | $4.94 | $228K |
| Apr 16, 2021 | Schreiber Christopher C | Director | Option exercise(M) | 132K | — | — |
| Apr 16, 2021 | Uzonwanne Jude | Director | Grant(A) | 116K | — | — |
| Apr 16, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 39K | — | — |
| Apr 16, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 77K | — | — |
| Apr 16, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 77K | — | — |
| Apr 16, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 96K | — | — |
| Apr 16, 2021 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant(A) | 96K | — | — |
| Apr 16, 2021 | Rivard Paul | EVP of Operations, GC | Grant(A) | 77K | — | — |
| Apr 16, 2021 | Rivard Paul | EVP of Operations, GC | Grant(A) | 77K | — | — |
| Apr 16, 2021 | Schroeder Robert C | Director | Option exercise(M) | 44K | — | $0 |
| Apr 16, 2021 | Schroeder Robert C | Director | Tax withholding(F) | 15K | $4.94 | $73K |
| Apr 16, 2021 | Schroeder Robert C | Director | Option exercise(M) | 44K | — | — |
| Apr 16, 2021 | Silverman Joshua | Director | Option exercise(M) | 110K | — | $0 |
| Apr 16, 2021 | Silverman Joshua | Director | Option exercise(M) | 110K | — | — |
| Apr 16, 2021 | Silverman Joshua | Director | Tax withholding(F) | 38K | $4.94 | $189K |
| Apr 16, 2021 | White Billy Joe | Director | Option exercise(M) | 110K | — | $0 |
| Apr 16, 2021 | White Billy Joe | Director | Tax withholding(F) | 38K | $4.94 | $189K |
| Apr 16, 2021 | White Billy Joe | Director | Option exercise(M) | 110K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).